Big Pharma Split (TSX:PRM.PR.A.PFD) EPS (Basic) : C$0.00 (TTM As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Big Pharma Split EPS (Basic)?

Big Pharma Split's basic earnings per share (Basic EPS) for the six months ended in Jun. 2024 was C$0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2024 was C$0.00.

Big Pharma Split's EPS (Diluted) for the six months ended in Jun. 2024 was C$0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was C$0.00.

Big Pharma Split's EPS without NRI for the six months ended in Jun. 2024 was C$0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was 0.00.

During the past 3 years, the average EPS without NRI Growth Rate was -34.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, Big Pharma Split's highest 3-Year average EPS without NRI Growth Rate was 28.00% per year. The lowest was -34.10% per year. And the median was -4.20% per year.

Big Pharma Split EPS (Basic) Historical Data

The historical data trend for Big Pharma Split's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Big Pharma Split EPS (Basic) Chart

Big Pharma Split Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

Big Pharma Split Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EPS (Basic)	Get a 7-Day Free Trial									-	-	-	-	-

Big Pharma Split EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Big Pharma Split's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.14	-	0.506)	/	0
	=

Big Pharma Split's Basic EPS for the quarter that ended in Jun. 2024 is calculated as

Basic EPS (Q: Jun. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(1.502	-	0.263)	/	0
	=

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was C$0.00

Big Pharma Split (TSX:PRM.PR.A.PFD) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Big Pharma Split EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Big Pharma Split's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Big Pharma Split Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM.PR.A.PFD) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

XN4:Germany PRM:Canada

Address

610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5

Website

https://www.harvestportfolios.com

Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.

Big Pharma Split Headlines

No Headlines